Involving patients in discussions on benefits and risks of medicines By Anna Jurczynska | May 19, 2017 Posted in Recent News and tagged benefits, chmp, Committee for Medicinal Products for Human Use, ema, European Medicines Agency, patients, pilot, risks ← New DGPharMed PresidentCommunication@EMA – how are we doing? →